Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Revenue

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹922 Cr₹819 Cr₹666 Cr₹560 Cr₹450 Cr

What is the latest Revenue of ORCHID PHARMA ?

The latest Revenue ratio of ORCHID PHARMA is ₹922 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹922 Cr
Mar2024₹819 Cr
Mar2023₹666 Cr
Mar2022₹560 Cr
Mar2021₹450 Cr

How is Revenue of ORCHID PHARMA Trending?

Years Revenue % Change
Mar2025 ₹922 Cr
12.52
Mar2024 ₹819 Cr
23.05
Mar2023 ₹666 Cr
19.00
Mar2022 ₹560 Cr
24.33
Mar2021 ₹450 Cr -

Compare Revenue of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹6,015.8 Cr 0.3% 7.7% 41.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹470,270.0 Cr -1.5% 2.5% 14.5% Stock Analytics
DIVIS LABORATORIES ₹222,224.0 Cr 7.4% 22.2% 26.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,325.0 Cr 3.1% 4.3% 38.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.6% -1.4% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,876.6 Cr 1.5% -15.2% -9.1% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

0.3%

7.7%

41.3%

SENSEX

2.2%

0.9%

-3.7%


You may also like the below Video Courses